INBODY CO.,LTD |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 29,750 KRW | +2.06% |
|
+5.31% | +17.36% |
| 2023 | InBody Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
| 2022 | InBody Releases BPBIO 220 and BPBIO 250 | CI |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Capitalization 1 | 314,589 | 226,016 | 301,572 | 263,142 | 330,231 | 387,549 | - |
| Enterprise Value (EV) 1 | 314,548 | 226,016 | 301,572 | 263,142 | 330,231 | 387,549 | 387,549 |
| P/E ratio | 15.4 x | 13 x | 8.87 x | 7.75 x | 8.99 x | 9.91 x | 8.48 x |
| Yield | 0.59% | 0.81% | 0.86% | 1.49% | 1.38% | 1.09% | 1.09% |
| Capitalization / Revenue | 2.69 x | 2.11 x | 2.19 x | 1.64 x | 1.94 x | 1.97 x | 1.74 x |
| EV / Revenue | 2.69 x | 2.11 x | 2.19 x | 1.64 x | 1.94 x | 1.97 x | 1.74 x |
| EV / EBITDA | 9.95 x | 9.58 x | 7.49 x | 5.71 x | 7.48 x | 7.53 x | 6.57 x |
| EV / FCF | 14.9 x | 8.43 x | 15.9 x | 10.5 x | 10.7 x | 10.9 x | 8.91 x |
| FCF Yield | 6.72% | 11.9% | 6.27% | 9.52% | 9.38% | 9.16% | 11.2% |
| Price to Book | 2.25 x | 1.51 x | 1.64 x | 1.22 x | 1.33 x | 1.39 x | 1.21 x |
| Nbr of stocks (in thousands) | 13,302 | 13,027 | 13,027 | 13,027 | 13,027 | 13,027 | - |
| Reference price 2 | 23,650 | 17,350 | 23,150 | 20,200 | 25,350 | 29,750 | 29,750 |
| Announcement Date | 02/03/20 | 26/02/21 | 25/02/22 | 23/02/23 | 22/02/24 | - | - |
1KRW in Million2KRW
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Net sales 1 | 117.1 | 107.1 | 137.8 | 160 | 170.4 | 197.2 | 222.1 |
| EBITDA 1 | 31.61 | 23.59 | 40.29 | 46.08 | 44.16 | 51.5 | 59 |
| EBIT 1 | 27.63 | 19.1 | 36.3 | 41 | 38.35 | 46.85 | 55.05 |
| Operating Margin | 23.6% | 17.83% | 26.33% | 25.62% | 22.51% | 23.76% | 24.79% |
| Earnings before Tax (EBT) 1 | 28.22 | 20.69 | 39.33 | 42.7 | 45.29 | 50.55 | 59.5 |
| Net income 1 | 20.43 | 17.45 | 33.99 | 33.94 | 37.38 | 41.35 | 48.45 |
| Net margin | 17.45% | 16.29% | 24.66% | 21.21% | 21.94% | 20.97% | 21.81% |
| EPS 2 | 1,532 | 1,335 | 2,609 | 2,605 | 2,819 | 3,002 | 3,508 |
| Free Cash Flow 3 | 21,134 | 26,814 | 18,914 | 25,039 | 30,983 | 35,500 | 43,500 |
| FCF margin | 18,054.29% | 25,031.26% | 13,721.75% | 15,649.05% | 18,187.6% | 18,002.03% | 19,585.77% |
| FCF Conversion (EBITDA) | 66,861.85% | 113,652.39% | 46,946.77% | 54,340.65% | 70,159.11% | 68,932.04% | 73,728.81% |
| FCF Conversion (Net income) | 103,454.46% | 153,653.01% | 55,646.36% | 73,782.05% | 82,894.81% | 85,852.48% | 89,783.28% |
| Dividend per Share 2 | 140.0 | 140.0 | 200.0 | 300.0 | 350.0 | 325.0 | 325.0 |
| Announcement Date | 02/03/20 | 26/02/21 | 25/02/22 | 23/02/23 | 22/02/24 | - | - |
1KRW in Billions2KRW3KRW in Million
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 33.04 | 38 | 38.6 | 39.43 | 38.89 | 43.08 | 40.66 | 44.75 | 41.91 | 44.3 | 47.5 | 49.5 | 52.6 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBIT 1 | 7.915 | 9.375 | 11.52 | 9.945 | 7.54 | 12 | 8.715 | 12.44 | 6.745 | 10.7 | 11.5 | 12.2 | 13 |
| Operating Margin | 23.95% | 24.67% | 29.84% | 25.22% | 19.39% | 27.85% | 21.43% | 27.8% | 16.09% | 24.15% | 24.21% | 24.65% | 24.71% |
| Earnings before Tax (EBT) | 8.905 | 8.743 | 12.21 | 11.29 | 10.99 | 8.215 | - | 14.31 | - | - | - | - | - |
| Net income 1 | 7.069 | 8.535 | 10.05 | 8.629 | 9.205 | 6.051 | 7.045 | 12.05 | 7.93 | 9.3 | 10 | 10.5 | 11.2 |
| Net margin | 21.39% | 22.46% | 26.04% | 21.89% | 23.67% | 14.04% | 17.33% | 26.93% | 18.92% | 20.99% | 21.05% | 21.21% | 21.29% |
| EPS | 543.0 | - | - | - | - | - | - | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 12/11/21 | 25/02/22 | 12/05/22 | 11/08/22 | 11/11/22 | 23/02/23 | 10/08/23 | 13/11/23 | 22/02/24 | - | - | - | - |
1KRW in Billions
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Net Debt | - | - | - | - | - | - | - |
| Net Cash position | 40.4 | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - |
| Free Cash Flow 1 | 21,134 | 26,814 | 18,914 | 25,039 | 30,983 | 35,500 | 43,500 |
| ROE (net income / shareholders' equity) | 15.5% | 12.1% | 20.4% | 17% | 15.8% | 15.4% | 15.6% |
| ROA (Net income/ Total Assets) | 14.3% | 10.9% | 18.4% | 15.2% | 14.2% | 13.8% | 14.2% |
| Assets 2 | 143.3 | 159.6 | 184.9 | 223.2 | 263.2 | 299.6 | 341.2 |
| Book Value Per Share 3 | 10,502 | 11,520 | 14,104 | 16,584 | 19,096 | 21,349 | 24,548 |
| Cash Flow per Share 3 | 1,815 | 2,188 | 2,346 | 2,335 | 2,970 | 3,809 | 4,387 |
| Capex 2 | 3.07 | 1.69 | 11.7 | 5.38 | 7.7 | 3 | 3 |
| Capex / Sales | 2.62% | 1.57% | 8.46% | 3.36% | 4.52% | 1.52% | 1.35% |
| Announcement Date | 02/03/20 | 26/02/21 | 25/02/22 | 23/02/23 | 22/02/24 | - | - |
1KRW in Million2KRW in Billions3KRW
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
29,750
KRW
Average target price
38,000
KRW
Spread / Average Target
+27.73%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +17.36% | 280M | |
| +8.00% | 217B | |
| +6.23% | 183B | |
| +11.02% | 131B | |
| +24.77% | 106B | |
| -0.95% | 62.16B | |
| +10.96% | 51.02B | |
| +4.81% | 50.89B | |
| -0.45% | 40.16B | |
| +1.45% | 34.79B |
- Stock Market
- Equities
- A041830 Stock
- Financials InBody Co.,Ltd
